Lyvgen Biopharma
Shanghai · Founded 2016
About Lyvgen Biopharma
Lyvgen Biopharma is a cross-linking-dependent antibody platform. The company also provides tumor immune agonistic antibody, local activation of the tumor microenvironment, and synthetic biology engineering services.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $40.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2021)
- Website: http://lyvgen.com
- Phone: 021-50663360
Industries & Categories
Biopharma, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/lyvgen-biopharma-47307 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.